Clinical applications of expression profiling and proteomics in prostate cancer.


Expression profiling and proteomics have the potential to transform the management of prostate cancer, identifying new markers for screening, diagnosis, prognosis, monitoring and targets for therapy. Expression profiling has revealed that the majority of prostate cancers contain fusion genes resulting in the upregulation of ETS family transcription factors… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics